Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 353,874 | 306,486 | 251,247 | 159,201 | 81,321 |
| Cost of Goods | 5,582 | 5,504 | 5,215 | 3,554 | 2,058 |
| Gross Profit | 348,292 | 300,982 | 246,032 | 155,647 | 79,263 |
| Operating Expenses | 220,672 | 189,880 | 156,751 | 103,346 | 69,142 |
| Operating Income | 128,202 | 111,606 | 89,496 | 52,855 | 10,179 |
| Other Income | 3,400 | 5,070 | 2,657 | -49 | -2,039 |
| Pre-tax Income | 131,602 | 116,676 | 92,153 | 52,806 | 8,140 |
| Income Tax | 25,591 | 22,495 | 16,743 | -76,316 | N/A |
| Net Income Continuous | 106,011 | 94,181 | 75,410 | 129,122 | 8,140 |
| Net Income | $106,011 | $94,181 | $75,410 | $129,122 | $8,140 |
| EPS Basic Total Ops | 0.92 | 0.82 | 0.65 | 1.14 | 0.07 |
| EPS Basic Continuous Ops | 0.92 | 0.82 | 0.65 | 1.14 | 0.07 |
| EPS Diluted Total Ops | 0.85 | 0.77 | 0.60 | 1.04 | 0.07 |
| EPS Diluted Continuous Ops | 0.85 | 0.77 | 0.60 | 1.04 | 0.07 |
| EPS Diluted Before Non-Recurring Items | 0.85 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $130,439 | $113,777 | $88,011 | $52,975 | $10,287 |